rabeprazole has been researched along with Sleep Wake Disorders in 3 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to examine the associations between sleep disturbances and refractory gastroesophageal reflux disease (GERD) symptoms in patients receiving once daily proton pump inhibitors (PPI) and the efficacy of twice-daily rabeprazole treatment." | 9.17 | Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment. ( Arakawa, T; Ashida, K; Fujiwara, Y; Habu, Y; Higuchi, K; Kusano, M, 2013) |
| "Rabeprazole treatment significantly decreased both the FSSG and the PSQI score." | 5.36 | Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole. ( Arakawa, T; Fujiwara, Y; Hayakawa, T; Kaji, M; Kohata, Y; Machida, H; Nebiki, H; Sasaki, E; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamasaki, T, 2010) |
| " The aim of this study was to examine the associations between sleep disturbances and refractory gastroesophageal reflux disease (GERD) symptoms in patients receiving once daily proton pump inhibitors (PPI) and the efficacy of twice-daily rabeprazole treatment." | 5.17 | Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment. ( Arakawa, T; Ashida, K; Fujiwara, Y; Habu, Y; Higuchi, K; Kusano, M, 2013) |
| "Rabeprazole treatment significantly improved subjective indices of sleep quality." | 2.71 | The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. ( Goodrich, S; Orr, WC; Robert, J, 2005) |
| "Rabeprazole treatment significantly decreased both the FSSG and the PSQI score." | 1.36 | Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole. ( Arakawa, T; Fujiwara, Y; Hayakawa, T; Kaji, M; Kohata, Y; Machida, H; Nebiki, H; Sasaki, E; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamasaki, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, Y | 2 |
| Habu, Y | 1 |
| Ashida, K | 1 |
| Kusano, M | 1 |
| Higuchi, K | 1 |
| Arakawa, T | 2 |
| Kohata, Y | 1 |
| Kaji, M | 1 |
| Nebiki, H | 1 |
| Yamasaki, T | 1 |
| Sasaki, E | 1 |
| Hayakawa, T | 1 |
| Machida, H | 1 |
| Tanigawa, T | 1 |
| Watanabe, K | 1 |
| Watanabe, T | 1 |
| Tominaga, K | 1 |
| Orr, WC | 1 |
| Goodrich, S | 1 |
| Robert, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect Of Pantoprazole 40 mg Once Daily Versus Placebo On The Power Spectral Analysis Of The Sleep Electroencephalogram (EEG) Of Patients With Gastroesophageal Reflux Disease (GERD)[NCT00674245] | Phase 2/Phase 3 | 40 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for rabeprazole and Sleep Wake Disorders
| Article | Year |
|---|---|
Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Topics: Adult; Aged; Aged, 80 and over; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Proton P | 2013 |
The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Ulcer Agents; Benzimidazoles; Female; | 2005 |
1 other study available for rabeprazole and Sleep Wake Disorders
| Article | Year |
|---|---|
Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Asian People; Female; Gastroesophageal Reflux; | 2010 |